drugset / Trial / NCT06890533

A Study of YZJ-4729 Tartrate Injection for the Treatment of Pain After Abdominal Surgery

NCT06890533

Phase 3 Active not recruiting 560 enrolled Shanghai Haiyan Pharmaceutical Technology Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective is to evaluate the analgesic efficacy and safety of IV YZJ-4729 Tartrate Injection in patients with acute postoperative pain following abdominal surgery.

Timeline

Start
2025-05-14
Primary completion
2026-04-17
Completion
2026-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Morphine Other / unclassified
Subject YZJ-4729 Unknown Intravenous

Indications

No indication recorded.